Gain Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Gain Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Gain Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $11K, a 48.8% decline year-over-year.
  • Gain Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $46.6K, a 67.4% decline year-over-year.
  • Gain Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $79.3K, a 14.7% decline from 2022.
  • Gain Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $93K, a 2220% increase from 2021.
  • Gain Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $4.01K, a 25.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $79.3K -$13.7K -14.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $93K +$89K +2220% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $4.01K -$1.38K -25.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $5.39K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.